IM Cannabis (IMCC) Total Non-Current Liabilities (2019 - 2026)
IM Cannabis (IMCC) posted quarterly Total Non-Current Liabilities of $805772.3 for Q1 2026, up 19.57% year-over-year from $673918.2 in Q1 2025, and down 16.46% quarter-over-quarter from $964481.1 in Q4 2025.
IM Cannabis (IMCC) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
IM Cannabis' Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $805772.3 for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 19.57% year-over-year to $805772.3; the TTM figure through Mar 2026 stood at $805772.3 (up 19.57% YoY), while the FY2025 annual figure was $964481.1, up 17.48% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $805772.3, down from $964481.1 in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $21.8 million in Q1 2022, with the low at $673918.2 in Q1 2025.
- The 5-year median for Total Non-Current Liabilities is $1.7 million (2023), against an average of $4.0 million.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities tumbled 85.0% in 2022, then soared 37.91% in 2025.
- IM Cannabis' Total Non-Current Liabilities stood at $2.3 million in 2022, then slipped by 26.13% to $1.7 million in 2023, then tumbled by 51.68% to $804614.4 in 2024, then climbed by 19.87% to $964481.1 in 2025, then retreated by 16.46% to $805772.3 in 2026.
- Business Quant data shows IMCC's Total Non-Current Liabilities at $805772.3 in Q1 2026, $964481.1 in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -13.28 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.45 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 33.50 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.76 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.37 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.42 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 334.00 Mn |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | 690,393.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 690,393.64 |
| Mar 31, 2026 | 805,772.29 |
| Dec 31, 2025 | 964,481.05 |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 673,918.23 |
| Dec 31, 2024 | 804,614.43 |
| Sep 30, 2024 | 862,803.86 |
| Jun 30, 2024 | 973,879.21 |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 3.41 Mn |
| Jun 30, 2023 | 4.55 Mn |
| Mar 31, 2023 | 4.60 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 2.96 Mn |
| Jun 30, 2022 | 17.42 Mn |
| Mar 31, 2022 | 21.79 Mn |
| Dec 31, 2021 | 15.03 Mn |
| Dec 31, 2020 | 14.76 Mn |